Protein kinase CK2 is a serine/threonine kinase known to phosphorylate numerous substrates. CK2 is implicated in several physiologic and pathologic processes, particularly in cancer biology. CK2 is comprised of several subunits, including CK2a, CK2a' and CK2b. Inactivation of CK2a' leads to chromatin degeneration of germ cells, resulting in male sterility. To identify additional targets of CK2a' in testes and to determine the role of CK2a' in germ cell nuclear integrity, GST pull-down and protein-protein interaction assays were conducted. A novel testis-specific gene, CKT2 (CK2 Target protein 2), was found whose product interacts with and is phosphorylated by CK2 in vitro and in vivo. CKT2 is a 30.2 kDa protein with one coiled-coil domain and six putative phosphorylation sites. High expression of CKT2 correlated with chromatin condensation of spermatids in murine testes. Findings reported herein demonstrate that CKT2 is a target protein of native CK2a' in testes and suggest that CKT2 plays a role in chromatin regulation of male germ cells.
INTRODUCTION
Protein Kinase CK2 is a serine/threonine phosphotransferase that exists primarily as a tetrameric structure with two catalytic subunits, CK2 alpha (CK2a) and CK2 alpha prime (CK2a 0 ), and two regulatory CK2 beta (CK2b) subunits (1) . CK2a and CK2a 0 are gene products of Csnk2a1 and Csnk2a2, respectively. A third isoform of the catalytic subunit, called CK2a 00 , is a larger variant of CK2a that has a translated Alu sequence at the C-terminus (2) . The human genome contains four CK2 loci, corresponding to three active genes, coding for the catalytic a and a 0 subunits, one regulatory b subunit, and a processed a subunit pseudogene (3) . CK2 has the unique ability to utilize GTP as a phosphate donor in place of ATP (4) .
CK2 has been reported to phosphorylate many physiological substrates (4) . More than one-third of the known 300+ protein substrates phosphorylated by CK2 are involved in gene expression and protein synthesis, either as transcription factors, effectors of DNA/RNA structure, or translation elements. Substrates for CK2 also function as signalling proteins and those essential for viral replication (5, 6) . Candidate cellular CK2 substrates include proto-oncogene products such as c-Myc, c-Myb and c-Jun; tumour-suppressor gene products such as p53 and BRCA1; transcriptional regulators such as Max, Cut, PU.1/IRF4 and Six1; and components of the canonical Wnt pathway (7) .
CK2 has been implicated in diverse cellular processes such as cell cycle regulation and cell growth, circadian rhythms, apoptosis, regulation of cell polarity, embryonic development, cell morphology and the cytoskeleton (4, 8, 9) . Increased constitutive activity of CK2 has also been implicated in the pathogenesis of various infectious diseases, neurodegenerative diseases and cardiovascular disorders (10) .
The best known pathogenic role for CK2 has been in neoplastic growth and high CK2 activity has been observed in numerous cancers (11) . Consistent with its ability to enhance cancer growth, CK2 promotes aberrant activation of nuclear factor-kappaB, suppression of cellular apoptosis and survival of breast cancer cells (12, 13) . It also induces lymphocyte transformation in transgenic mice, collaborates with Ha-Ras in fibroblast transformation, and is involved in the pathobiology of androgendependent and -independent prostate cancer (14, 15) . CK2 can exert an anti-apoptotic role by protecting regulatory proteins from caspase-mediated degradation and counteracting caspase cleavage (6) . As a result of its cancer-promoting properties, CK2 has been considered to be a target of anti-neoplastic treatments (16, 17) .
The catalytic subunits of CK2-CK2a and CK2a 0 -are paralog proteins. Typically, the evolution of paralog proteins is associated with a functional specialization (18) .
CK2a and CK2a
0 exhibit approximately 90% identity in their catalytic domains, but mainly differ in their C-terminal region (18) . CK2a' and CK2a are significantly different with respect to some well-known CK2 properties such as autophosphorylation and supra-molecular aggregation (18) . Abundance of CK2a 0 -containing holoenzyme in certain tissues suggests an important role of CK2a 0 in these tissues (18, 19) . Indeed, CK2a is the more abundant CK2 subunit in developing embryos ad in contrast to CK2 0 À/À embryos, CK2À/À embryos die in mid-gestation (20) . A pro-neoplastic role for CK2a 0 has been demonstrated in that human osteosarcoma U2-OS cell proliferation is inhibited following the over-expression of a kinase inactive variant of CK2a 0 , but not of CK2a (15) . CK2a 0 is found predominantly in testis (21, 22) . Our previous studies showed that male mice lacking CK2 0 were infertile and exhibited an abnormal shape in their spermatid nuclei (23) . In addition, a significant number of germ cells in the CK2 0 À/À mice were eliminated by apoptosis (23) . Moreover, male germ cells at various steps of differentiation showed unique perturbations of chromatin and nuclear envelope in the CK2 0 À/À mice (24) . Therefore, the phenotype of the CK2 0 À/À mice suggests that CK2a 0 has a role in cell survival, in maintaining nuclear integrity of male germ cells, and raises the question of whether dysregulated expression of CK2a 0 may be involved in testicular malignancy.
Compared to other CK2 subunits, significantly less is known about CK2a 0 . To better understand the testisspecific function of CK2a 0 , the yeast two-hybrid technique was used to identify protein(s) that can interact with testicular CK2a 0 . As we will show, a new gene designated CKT2 (CK2 Target protein 2) was identified in the mouse chromosome 16 and specifically expressed in mouse testes. Furthermore, we will show that CKT2 is a target protein of CK2a 0 , is phosphorylated by CK2, and is present in the nuclei of mouse spermatids during chromatin condensation.
MATERIALS AND METHODS
Detailed descriptions of the following Materials and Methods are given in the Supplementary data: reagents and molecular tools, and Southern blot.
Construction of plasmids for two-hybrid experiments
The ORF region of CK2 0 , CK2 and CK2 were cloned into the Gal4 DNA-binding domain vector pGBKT7. ORF N-and C-terminal regions of CKT2 were cloned in Gal4 transcriptional activation domain vector pACT2; all plasmids were constructed by standard molecular biology methods (25) and confirmed by sequencing.
Yeast two-hybrid screen and cDNA isolation
The full length murine CK2 0 cDNA was cloned into the pGBKT7 vector in the in-frame fusion of CK2 0 with the DNA-binding domain of the yeast GAL4 protein.
A mouse testis cDNA library containing 4.5 Â 10 6 independent clones (Clontech Laboratories Inc.) was cloned into pACT2 to produce fusions between the targeted proteins and the cDNA activation domain of GLA4. Screening was performed by sequential transformation of bait and library vectors in Saccharomyces cerevisiae strain Y190 used for the screening assay containing his, ade and lacZ reporter genes under the control of a GAL4-responsive upstream activation site. Transformants were plated on SC-Leu-Trp-Ade-His-medium and incubated at 308C for up to 3-5 days. A cDNA for the CKT2 gene was obtained from 2 Â 10 6 transformants of mouse testis cDNA in pACT2 and using CK2 0 as bait in pGBKT7 clones. A testis cDNA library in gt11 was screened for the selected clone 8. For the localization of CKT2 gene, the mouse BAC genome DNA was used (Clontech Laboratories Inc.). The DNA sequencing was performed at Yale University, and the GenBank database was searched by using the BLAST program (National Center for Biotechnology Information, Bethesda, MD, USA).
Isolation of RNA and RT-PCR
Total RNA was isolated from different organs of adult mice as described previously (26) . RT-PCR using the Advantage RT-PCR Kit (Promega Corp.) was performed according to the manufacturer's instruction. The following primers were used: primer of sense mouse -actin 5 0 -G CTGTGTTCCCATCCAT-CGTGG-3 0 (nt1, 875-1896) and antisense mouse -actin 5 0 -GACGCATGATGGCG-GTGTGGCA-3 0 (nt 2561-2540), CKT2 sense primer 5 0 -C AATTCCATCTCCAAGTCTAC-3 0 (nt 451-472) and CKT2 antisense primer 5 0 -TCAGGATTTCTCATTTTG AAAC-3 0 (nt 1339-1317).
Recombinant proteins
To produce the CKT2 and CK2 subunit recombinant protein, the coding region of CKT2 and CK2 subunit cDNA was amplified by PCR using primers representing the first, middle and last 20 nucleotides of CKT2 and CK2. The upstream and downstream primers contained at their 5 0 -ends a BamHI and EcoRI restriction enzyme recognition site, respectively. The PCR product was unidirectionally cloned into pGEX2 vector to create pGCKT2 (1-276), pGCKT2-n (1-137) and pGCKT2-c (138-276) GST fusion vectors. For expression, Escherichia coli BL21 were used. The cells were first grown at 308C to an optical density of 0.8, induced with 0.5 mM final concentration of isopropyl-b-D-thiogalactopyranoside (IPTG), and incubated at 308C for another 5 h before harvesting the culture. The recombinant protein was purified on glutathione-Sepharose TM 4B (Amersham Biosciences AB, Uppsala Sweden), and the protein concentration was determined by the Bradford Protein Assay (Bio-Rad Laboratories, Hercules, CA, USA).
Antibody preparation
The (1-276) and (138-276) CKT2 cDNA were constructed in pGEX2 vector (Pharmacia). The recombinant proteins were expressed in Escherichia coli BL21 and purified by glutathione-sepharose beads (Pharmacia). The recombinant proteins were injected into female mice to produce monoclonal antisera against CKT2. For polyclonal antibodies, peptides encompassing 83-102 and 257-276 CKT2 amino acids were synthesized; conjugated to KLH and injected into rabbits. Antisera were purified by affinity to CKT2 peptide.
In situ hybridization
Paraffin-embedded testicular sections of C57BL/6J adult male mice were fixed in freshly prepared 4% paraformaldehyde in PBS. The cDNA fragment of CKT2 was cloned into vector pBluescript II KS + containing two RNA transcription promoters, T3 and T7, to be named pBCKT2. The sense probe was synthesized using T3 RNA polymerase and the plasmid was linearized with XhoI, whereas the antisense probe was synthesized using T7 RNA polymerase and the plasmid was linearized with EcoRI. In situ hybridization (ISH) was performed using 35 S-labeled antisense or sense probes transcribed from full-length cDNA for CKT2 by using a Superscript kit (Promega Corp.). Tissue section ISH was performed as previously described (26) .
Immunohistochemistry
Testes were decapsulated, fixed for 3 h in 4% paraformaldehyde in PBS (phosphate-buffered saline) and then incubated in sucrose solutions of increasing concentration (12%, 15% and 18%) before freezing and sectioning. Sections were incubated with anti-CKT2 antibody (diluted 1/100). Controls were performed as for immunoelectron miscroscopy (see below). Immunohistochemical labeling was performed with the three-step immunoperoxidase technique using the biotin-avidin system (Vector Laboratories, Burlingame, CA, USA). Amino-ethyl-carbazole was used as the chromogen. Sections were counterstained with Harris hematoxylin and mounted in aqueous medium (Glycergel, Dako Corp., Carpinteria, CA, USA).
Immunoelectron microscopy
Testes from 2-to 3-month-old C57BL/6J mice were fixed with 4% paraformaldehyde at 48C overnight for postembedding immunolabeling. The samples were washed several times in 1ÂPBS and subsequently dehydrated with a series of graded ethanol solutions, then embedded in Lowicryl K4M and crosslinked under UV for 3 days at 48C. Ultrathin (900 nm) sections were dehydrated with PBT/nonfat milk [PBS, pH 7.2, 0.05% (v/v) Tween 20, 0.1% (w/v) nonfat milk] for 15 min and incubated with anti-CKT2 antibodies for 2 hrs, extensively washed with PBT, and incubated for 1 h with secondary IgG antibody labeled with colloidal gold (15 nm gold particles; BBInternational, Cardiff, UK), both diluted 1/100 in PBS/nonfat milk. Grids were then washed in PBT and rinsed in distilled water. Control experiments were performed by (i) omission of the anti-CKT2 antibodies, (ii) replacement of anti-CKT2 antibodies by preimmune serum and (iii) preincubation of CKT2 antibodies with the specific CKT2 peptide. Counterstaining was omitted. The ultrastructural examination of the tissues was performed using a JEOL (JEM 100CX II) (Jeol Ldt, Tokyo, Japan) electron microscope operating at 80 Kv, and photographs taken on Kodak electron microscopy film.
b-galactosidase filter and liquid assay
Single colonies were picked and transferred to a Whatman filter paper (No. 5) for b-galactosidase assay; the filter and liquid assay were performed as previously described (26) .
Cell culture and transfection
HEK293 cells were cultured in Fugene's medium (Boheringer Mannheim, Germany) following the company's description and supplemented with 10% fetal bovine serum (Invitrogen, BV NV Leek, Netherlands) at 378C in a 5% CO 2 incubator. A Flag tag was fused to CKT2 and subcloned into pcDNA3 expression vector (Invitrogen) and the DNA construct was verified by direct sequencing. The cells were transfected using the calcium phosphate precipitation method as described previously (27) , using 50 mg of DNA per 8 Â 10 6 cells in a 15-cm diameter plate. Co-transfection experiments used equivalent amounts of DNA for each plasmid unless otherwise indicated. Cells were washed thoroughly with PBS and replenished with fresh medium at 16-18 h after transfection. After 3 days, the cells were fixed in 2% paraformaldehyde and stained with M2 anti-Flag antibody (Sigma Aldrich). Following addition of a secondary anti-mouse IgG antibody coupled to FITC, immunofluorescence was detected.
Glutathione S-transferase pull-down assay GST pull-down assay was performed with purified GST-CKT2 fusion protein. Method 1 (GST-CKT2 plus labeled 35 
S-CK2
0 or 35 S-CK2): CK2a 0 or CK2a subunits labeled with [ 35 S] methionine were synthesized by coupled transcription translation with wheat germ extract from a TnT kit (Promega Corp.) and with T7 polymerase according to manufacturer's instructions. For in vitro binding, 20 ml of the reaction was added to 200 ml of binding buffer (100 mM KCl, 10% glycerol, 5 mM EDTA/ 20 mM Hepes, pH 7.6, 0.02% NP40, 1 mM DTT, 5 mg/ ml BSA) followed by 10 ml of glutathione-agarose beads with bound GST or GST-CKT2 and the mixture was incubated at 48C. The beads were washed three times with binding buffer. Bound proteins were eluted with 2Â SDS-PAGE sample buffer and were resolved by 12% SDS-PAGE. 35 S-labeled bands were detected by X-ray autoradiography using a PhosphoImager 425 (Molecular Dynamics, Sunnyvale, USA). Method 2 (GST-CKT2 plus testicular lysate): 20 ml of glutathioneagarose beads bound to GST-CKT2 or GST were incubated at 48C with 30 ml of testicular lysates from either the wildtype or CK2 0 null mice. The beads were 
In vitro kinase assays
The specific CK2 inhibitor peptides were ETERRREEE TEEE and DSDRRRDDDSDDD (Gift from Dr D.C. Seldin, Boston, MA, USA). CK2 peptide without a phosphorylation site (RETSALLRYFQTKFQNEKS) was used as control. The GST-CKT2 fusion proteins were expressed in recombinant Escherichia coli and immobilized on glutathione-agarose beads. GST-CKT2 beads were then incubated with 10 mg of protein lysates of mouse testes (wildtype or CK2 0 mutant) at 48C for 2 h, then washed three times with buffer (20 mM Tris-HCl at pH 7.5, 200 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 1% Triton X-100, 0.1 mM dithiothreitol, 1 mM PMSF protease inhibitor). The samples were then incubated in 400 ml buffer (100 mM Tris, pH 8.0 20 mM MgCl 2 , 100 mM NaCl, 50 mM KCl and 100 mM ATP containing 5 mCi of g-32 P-ATP) at 308C for 30 min. The kinase reactions were terminated by washing the samples twice and re-suspending the samples in SDS sample buffer. Then the samples were boiled for 5 min and the proteins were resolved by SDS-PAGE. Phosphorylated proteins were visualized and quantified by PhosphoImager analysis.
Immunoprecipitation, western blot analysis and CK2 kinase assay
Immunoprecipitation. Testicular cell extracts of C57BL/6J mice were prepared by griding mice testicles with a lysis buffer containing phosphatase and protease inhibitors [50 mM Tris-HCl, pH 7.5, containing 0.5% (v/v) Nonidet P-40, 1 mM EDTA, 150 mM NaCl; 5 mg/ml aprotinin, 5 mg/ml leupeptin, 2 mM Na 3 VO 4 , 1mM PMSF]. After centrifuging the lysates at 20 800g at 48C for 15-30 min, the protein concentrations were determined. One hundred mg aliquots of the testicular lysates were incubated with the anti-CKT2 antibody (2 mg/ml) or the anti-CK2a 0 antibody (2 mg/ml) overnight at 48C with gentle rotary mixing. The protein-antibody complexes were isolated by the addition of 20 ml protein A-sepharose beads (Santa Cruz), followed by gentle rotary mixing for 2 h at 48C. The beads were then washed three times with wash buffer [20 mM Tris-HCl at pH 7.5, 200 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 1% (v/v) Triton X-100, 1 mM DTT, 1 mM PMSF].
Western blot. The bead pellets obtained were resuspended in 30 ml 1Â Laemlli/DTT buffer, incubated for 5 min at 958C, and then separated by SDS-PAGE. The separated proteins were transferred onto PVDF membranes (Millipore) by electroblotting. The blotted membranes were blocked with 1ÂTBS containing 5% (w/v) nonfat milk and 0.05% (w/v) Tween-20 for 1 h at room temperature to reduce any nonspecific interactions. After multiple washings with 1ÂTBS, the membrane was incubated with anti-CK2a 0 antibody for 1 hr in 1ÂTBS containing 5% (w/v) nonfat milk. After additional washes, the membranes were incubated with HRPconjugated secondary antibodies (1:2000) for 60 min at room temperature in 1ÂTBS containing 5% (w/v) nonfat milk. After additional washings, the membranes were developed using an enhanced chemiluminescence detection kit (Cell Signaling Technology) and XAR sensitive film (Amersham Biosciences).
CK2 kinase assay. The CK2a
0 immunoprecipitated pellets obtained were resuspended in 25 ml of kinase buffer (100 mM sodium orthovanadate, 100 mM Tris-HCl (pH 8), 100 mM sodium chloride, 20 mM MgCl 2 , 50 mM KCl, 100 mM ATP containing 5 mCi of [g-32 P] ATP and 5 mg/ml CK2 casein). Kinase reactions were incubated for 15 min at 378C and stopped by the addition of 10 ml of reducing solubilizing buffer [50 mM Tris-HCl, (pH 6.8), 100 mM DTT, 2% (w/v) SDS, 0.1% (w/v) bromphenol blue, 10% (v/v) glycerol]. Samples were boiled for 10 min and subjected to SDS-PAGE. After electrophoresis, the gels were fixed for 20 min in a solution containing 40% (v/v) methanol and 10% (v/v) acetic acid. These were washed once with distilled water before being dried under vacuum and subjected to autoradiography.
Metabolic labeling
HEK293 cells (500 000 cells/well in a 6-well tissue culture plate) were transfected with pcDNA3 or pcDNA3-CKT2 plasmid using Lipofectamine 2000 according to manufacturer's instructions (Invitrogen) and then cultured for 24 h. The cells were then washed twice with phosphatefree DMEM supplemented with 10% heat-inactivated FBS. The cells were then incubated with 1 mCi/ml [ 32 P]-orthophosphate in the same medium for 6 h (28). The cells were lysed, centrifuged, and the supernatant of the cell lysates were immunoprecipitated with 1 mg anti-CKT2 antibody per condition. The immunoprecipitated CKT2 was separated by SDS-PAGE, transferred to a nitrocellulose membrane and subjected to autoradiography. Total CKT2 was qualitatively determined by immunoblotting the same membrane with 1:1000 anti-CKT2 antibody.
RESULTS

Isolation of murine CK2a' interacting partners
To identify proteins that can interact with CK2a 0 , a yeast two-hybrid screening was performed using the GAL4 recognition site to regulate expression of his, Ade and LacZ reporter genes. The GAL4-DB-CK2a 0 fusion protein alone did not activate transcription of the reporter genes (GAL4-DB: GAL4 DNA-binding domain). The GAL4-DB-CK2a 0 plasmid pGBKT7 was co-transformed with the GAL4-AD-cDNA library of mouse testis pACT2 into the AH109 strain of S. cerevisiae (GAL4-AD: GAL4 activation domain). Transformants were plated on SC-Leu-Trp-Ade-His-selective medium. Fifteen candidates positive for CK2a 0 were obtained from 2 Â 10 6 yeast cells co-transformed with murine testicular cDNA library in pACT2 and with CK2a 0 in pGBKT7 plasmid as bait. Sequence analysis showed that 13 of them were CK2, one was CKT1 (unpublished data), and one was a new gene designated CKT2, which was further analyzed.
Characteristics of CKT2
Since a putative translational initiation codon was missing in this cDNA CKT2 clone, a mouse testis cDNA library in gt11 was screened to isolate corresponding clones and used as a probe. The sequence of the full-length cDNA was accepted in Genbank (accession number NM_173861; NCBI interim symbol is Ckt2). Analyses of CKT2 DNA sequence showed that the ORF of CKT2 encodes a 276 amino acid protein corresponding to a 30.2 kDa gene product ( Figure 1A ). The first start codon (ATG) of the ORF began at position 511 and was preceded by an in-frame stop codon at position 21 to 24 and by a purine (A) at position 3. The deduced amino acid sequence of CKT2 showed a 23.9% homology with c-Myc (Supplementary Figure 1) . According to the consensus sequence (S/T)XX(D/E) that is phosphorylated by CK2, analysis of the CKT2 sequence revealed six putative CK2 phosphorylation sites ( Figure 1A) . A stretch of residues located at position 75-108 exhibited a strong probability of coiled-coil formation, as confirmed by the use of the coiled-coil domain prediction program (www.ch.embnet.org) ( Figure 1B) .
To localize the CKT2 gene, a Southern blot was performed with BAC mouse genome DNA and cDNA of CKT2 as probe (Figure 2A) . A 1.6 kb EcoRI fragment was cloned and sequenced and the CKT2 gene was localized in BAC number 8 of the mouse genome. The sequence of 1.6 kbp EcoRI fragment was compared to CKT2 cDNA nucleotide (Supplementary Figure 2) . Mouse Genome Blast database (WU-BLAST 2.0) and Celera Genomics Database indicated that CKT2 was an unknown gene localized to mouse chromosome 16.
Expression of CKT2 in mouse testis
Reverse transcription coupled with PCR amplification (RT-PCR) was performed to determine which mouse tissue(s) expressed CKT2. RT-PCR was performed on total mRNA isolated from different tissues to amplify the region encompassing an 880 bp fragment of CKT2 from mouse testis-derived cDNA. As shown in Figure 2B (top panel), an 880 bp RT-PCR product corresponding to CKT2 mRNA was found exclusively in mouse testes. Figure 2B (middle panel) shows b-actin control for the RT-PCR reactions. In order to confirm that this RT-PCR fragment corresponded to CKT2, a Southern blot was performed using a 32 P-labeled pCKT2 cDNA fragment excised by EcoRI/XhoI. As shown in Figure 2B (bottom panel), a strong positive signal for CKT2 gene was obtained in the testes. These results show that in the mouse, CKT2 is specifically expressed in the testes.
A western blot of mouse testicular lysates using a mouse monoclonal antibody against CKT2 revealed a protein of about 30-31 kDa, consistent with the size of CKT2 protein as predicted by the ORF of the CKT2 gene ( Figure 2C ). These findings indicate that the cloned CKT2 cDNA encodes the full-length CKT2 protein.
To further investigate CKT2 expression in the mouse testes, we performed in situ hybridization on sections of adult mouse testes, using a 35 S-labeled pBCKT2/EcoRI antisense riboprobe or a negative control 35 S-labeled pBCKT2/XhoI sense Riboprobe. No signal was present in testis section hybridized with the sense probe ( Figure 3A) . Sections of the testes hybridized with antisense probe showed a CKT2 mRNA signal localized in the seminiferous tubules, while the signal was absent in Figure 3B ). A weak signal was located in the basal compartment containing spermatogonia and in the adluminal compartment within condensed spermatids; Figure 3C shows these three compartments in an H & E stained mouse seminiferous tubule. These results indicate that CKT2 was specifically expressed in male germ cells undergoing differentiation at stages of spermatocytes and young spermatids. However, expression of CKT2 mRNA cannot be excluded in Sertoli cells. CKT2 expression in spermatogonia was found to be low, as compared to germ cells at more advanced stages of spermatogenesis and as shown by immunohistochemistry (see below).
CKT2 localizes to the nuclei of spermatids
As shown in Figure 4A , mouse testicular sections immunostained with anti-CKT2 antibody revealed that CKT2 was predominantly expressed in the nuclei of spermatids (asterisks) and, to a lesser extent, in the nuclei of some spermatogonia (arrow). Testes incubated with nonimmune IgG revealed absence of staining ( Figure 4B ). Sub-cellular localization of CKT2 in male germ cells was further investigated by immunogold labeling with anti-CKT2 antibody of mouse testis sections embedded in Lowicryl followed by electron microscopy. As shown in Supplementary Figure 3 , CKT2 expression varied with the stage of chromatin condensation. During the initial steps of chromatin condensation, CKT2 labeling was weak in the spermatids (Supplementary Figure 3A) but increased during the intermediate stages of chromatin condensation (Supplementary Figure 3B) . In more mature spermatids, the labeling decreased in the apical nuclear region with greater condensed chromatin, as compared to the less condensed posterior region ( Figure 4C -E and Supplementary Figure 3C and D). CKT2 was absent in spermatids with fully condensed chromatin (data not shown). These findings indicate a correlation between a high expression of CKT2 and the step of chromatin condensation in spermatids. The nuclear localization of CKT2 was confirmed in HEK293 cells transfected with Flag-CKT2. As shown in Figure 5 , staining of the transfected HEK293 cells with FITC-labeled anti-Flag antibody revealed that CKT2 was found in the nuclei, confirming that CKT2 is a nuclear protein.
CKT2 interacts with the CK2a' subunit of CK2
In order to determine whether CKT2 interacts with CK2 subunit(s), we used three experimental approaches: yeast two-hybrid assay, glutathione S-transferase (GST) pulldown assay, and co-immunoprecipitation. In the first approach, cDNAs encoding CK2a, CK2a 0 or CK2b subunit were each ligated into pGBKT7 vectors using the yeast two-hybrid technique. cDNAs encoding either the full length, the N-terminus, or the C-terminus of CKT2 were ligated into pACT2 vectors in order to express each as a fusion protein with the DNA-binding domain (pGBKT7), or with the transcriptional activation domain (pACT2) of the yeast Gal4 transcription factor. The S. cerevisiae strain HA109, which expresses b-galactosidase activity under the control of a Gal1 promoter upon binding by the Gal4 transcription factor, was then co-transformed with various combinations of pGBKT7 and pACT2 constructs. An indication for interaction between fusion proteins was measured by b-galactosidase activity in extracts from the various transformants.
CKT2 was found to strongly interact with CK2a 0 with a b-galactosidase activity of 5.8 AE 0.3 (Table 1) . By contrast, CKT2 minimally interacted with the CK2a subunit, with b-galactosidase activity that is nearly 6-fold less than seen with the CKT2-CK2a 0 interaction. CKT2 essentially did not bind to CK2b (Table 1) . Since the yeast twohybrid system showed that 13 yeast colonies contained CK2b, it suggested that CKT2 is a true target protein of CK2a 0 since CK2a 0 interacts with CK2b. This is also supported by the observation that clones of CKT2 and CK2b appeared simultaneously after co-transformation in S. cerevisiae strain AH109 (data not shown).
To investigate which region of CKT2 binds to CK2a 0 , we constructed the full length, N-terminus and C-terminus portions of cDNA as binding domains. A co-transformation was performed with CK2a 0 as the active domain in S. cerevisiae strain AH109 for b-galactosidase filter and liquid assay. The b-galactosidase activity was >2-fold greater with the C-terminus region (BD-CKT2 138-276) than the N-terminus region (BD-CKT2 1-137), and modestly higher than the full-length BD-CKT2 (Table 2 ). These data indicate that CK2a 0 preferentially interacts with the C-terminus region of CKT2 but that there was modest binding to the N-terminus as well.
CKT2 binds to CK2a' but not to CK2a in vitro
In a second approach to determine if CK2a 0 interacts directly with CKT2, a GST pull-down assay was performed. Two methods were used. In the first method, CK2a 0 or CK2a were translated under the T7 promoter and labeled with the beads three times, GST was cleaved from the glutathione-sepharose beads. The supernatants were separated by SDS-PAGE and subjected to autoradiography. As shown in Figure 6A (lane 1), GST protein alone did not bind to 35 S-labeled CK2a 0 . However, after incubating GST-CKT2 with 35 S-CK2a 0 and electrophoresis, autoradiography revealed two protein bands which corresponded to CK2a 0 ( Figure 6A, lane 2) . The presence of two isoforms of CK2a 0 is likely related to the presence of two methionine start codons during in vitro translation. The electrophoretic location of CK2a 0 was confirmed by electrophoresing only 35 
S-CK2a
0 ( Figure 6A, lane 3) . As shown in Figure 6B (lane 1), GST protein alone did not bind to 35 S-labeled CK2a. In contrast to CK2a 0 binding to CKT2, no bands were detected after incubating the GST-CKT2 fusion protein with 35 S-CK2a ( Figure 6B, lane 2) . Figure 6B , lane 3 contains only the labeled 35 S-CK2a. These data confirmed that CKT2 can bind to CK2a 0 but not to CK2a.
In a second method to examine the binding of CKT2 to CK2a 0 and/or CK2a subunits, 10 mg of GST or GST-CKT2 fusion protein were incubated with 50 mg of testicular lysates from either wildtype or CK2 0 À/À mice (23), precipitated with glutathione-sepharose beads, and analyzed by western blot with combined anti-CK2a and anti-CK2a 0 antibodies. As shown in Figure 6C , a western blot of whole testicular lysates confirmed the presence of both CK2a and CK2a 0 in the wildtype mice (lane 4) and only CK2a in the CK2 0 À/À mice (lane 5). As also shown in Figure 6C (lane 1), GST protein alone did not bind CK2a or CK2a 0 when GST was incubated with testicular lysates from the wild-type mice. Despite the fact that the relative band intensity for CK2a was greater than for CK2a 0 in the testicular lysates from wild-type mice (lane 4), the band intensity for CK2a was weaker in the GST-CKT2 pulldown assay following incubation with testicular lysates from the wild-type mice. This suggests that the binding of CKT2 to CK2a is significantly weaker than to CK2a 0 . Importantly, no bands were observed when testicular lysates from CK2 0 À/À mice were incubated with GST-CKT2 (lane 3). These results confirm the findings of the yeast two-hybrid and the biosynthetic GST-pull-down assays that CKT2 binds to CK2a 0 . In addition, it shows that CKT2 can also interact with CK2a but only in the presence of CK2a 0 .
CKT2 binds to CK2a' endogenously
We previously showed that the CK2a 0 subunit of CK2 binds to recombinant CKT2. Using a third approach to confirm that CK2a 0 binds to CKT2 endogenously, we determined whether CK2a 0 co-immunoprecipitated with CKT2 in testicular lysates. Mice testicular lysates were incubated with anti-CKT2 antibody as described in Materials and methods section. As shown in that CK2a 0 co-immunoprecipitated with CKT2 (lane 2) whereas CK2a 0 was not detected in lysates immunoprecipitated with a nonimmune IgG (lane 3).
CK2 phosphorylates CKT2 in vitro and in vivo
Based on the consensus sequence (S/T)XX(D/E) that is phosphorylated by CK2, CKT2 contains six potential CK2-mediated phosphorylation sites at positions 54 (Figure 1) . Hence, we further substantiated the functional significance of CKT2-CK2 interaction by examining the phosphorylation of CKT2 by CK2 using three different approaches. First, to determine which subunit(s) of CK2 could phosphorylate CKT2, we incubated purified recombinant CKT2 with recombinant CK2a 0 b, CK2ab, CK2a 0 , CK2a, CK2b or CK2a 0 ab in an in vitro phosphorylation assay. As can be seen in Figure 8A 
GST-CKT2-f.l. Figure 8A , lower panel, lane 6). As also shown, neither CK2ab, CK2a 0 , CK2a nor CK2b alone were capable of phosphorylating CKT2. However, CKT2-GST was phosphorylated by recombinant CK2a 0 b (lane 1), indicating that the regulatory subunit CK2b was required for CK2a 0 kinase activity. Second, in vitro kinase assays were also performed with recombinant CKT2 and CK2 kinase in the presence of a competitive inhibitory peptide of CK2 that contains a phosphorylation site for CK2. A noninhibitory peptide without a CK2 phosphorylation site served as a control. A Coomassie stain showed equal loading of GST-CKT2 among experimental conditions ( Figure 8B, upper panel) . Whereas the control peptide did not significantly inhibited such phosphorylation ( Figure 8B, bottom panel, lane 3) , the CK2 inhibitory peptide strongly inhibited CK2 phosphorylation of CKT2 ( Figure 8B , bottom panel, lanes 4 and 5). To confirm these results, in vitro phosphorylation of CKT2 with recombinant CK2 was performed in the presence of heparin, a polyanion known to inhibit CK2 activity (27) . Shown in Figure 8C Third, since the activity of CK2 is high in testes, we examined whether GST-CKT2 full length or GST-CKT2-C-terminus could be phosphorylated by testicular lysates from wildtype and CK2 0 À/À mice in an ex vivo approach (21) . Thus, mouse testicular lysates were used as a kinase source for the phosphorylation reactions. As shown in Figure 8D , GST protein alone was not phosphorylated by testicular lysates from the wild-type mice. As also demonstrated, both GST-CKT2 C-terminus and GST-CKT2 full length were robustly phosphorylated by testicular lysates from wild-type mice (lanes 2 and 4, respectively). These results indicate that CKT2 is phosphorylated by native cellular CK2 and that CK2a 0 is the essential subunit for CK2 phosphorylation activity. Although there was minimal phosphorylation of the substrates by the testicular lystates from the CK2 0 À/À mice (lanes 3 and 5, respectively), it suggests that kinases other than CK2a is responsible since the in vitro data with recombinant proteins showed that CKT2 was not phosphorylated by either CK2a or CK2ab ( Figure 8A) .
To determine whether endogenous CKT2 can be phosphorylated by CK2, CKT2 was co-immunoprecipitated with CK2a 0 from testicular lysates using anti-CK2a 0 antibody and protein A-sepharose beads. After washing the beads, an in vitro CK2 kinase assay was performed by adding to the immunoprecipitate mixture [g-32 P]-ATP and CK2 casein (see Materials and Methods section). As shown in Figure 9A , immunoprecipitated CKT2 was phosphorylated by CK2 (lane 1). In contrast, testicular lysates incubated with nonimmune IgG showed no phosphorylation by CK2 (lane 2).
To determine whether CKT2 can be phosphorylated endogenously by CK2 in vivo, we metabolically labeled CKT2-transfected HEK293 cells with [ 32 P]-orthophosphate, followed by immunoprecipitation with anti-CKT2 antibody. In an analogous fashion, Li and co-workers (28) previously showed that HEK293 cells contain CK2 and have used this cell line to show that CK2 phosphorylates the transfected ARC protein in vivo. The immunoprecipitate was separated by SDS-PAGE and subjected to autoradiography. As shown in Figure 9B , HEK293 cells transfected with the empty vector did not reveal a phosphorylated band consistent in size with CKT2. However, in cells transfected with the plasmid that encodes for CKT2, phosphorylated CKT2 was detected in the immunoprecipitate. In the presence of a CK2 inhibitor (DRB), there was significant decrease in the cellular phosphorylation of CKT2. Immunoblotting of the same nitrocellulose membrane with anti-CKT2 revealed equal amounts of total CKT2. We conclude from these studies that CKT2 can be phosphorylated by CK2 both in an in vitro kinase assay as well as endogenously as detected by metabolic labeling. 
DISCUSSION
CK2 is an intracellular signalling molecule known to phosphorylate many substrates (6) . Indeed, it has been proposed that the number of proteins phosphorylated by CK2 may be much more numerous than those identified to date (6) and that CK2 alone may be responsible for the generation of a relatively large proportion (10-20%) of the eukaryotic phosphoproteome (10) .
We identified a novel gene CKT2 whose product CKT2 is a target for CK2. RT-PCR and ISH studies showed that expression of CKT2 is testis-specific. Furthermore, immunohistochemistry and immunocytochemistry revealed that CKT2 is localized to the nuclei of male germ cells. Although CKT2 does not appear to have a nuclear localization signal (NLS) peptide, this sequence is not known to be required for proteins <45 kDa because they are able to passively diffuse through nuclear pore complexes (29) .
Survey of the CKT2 sequence showed that it contains a coiled-coil domain and six putative CK2 phosphorylation sites, one of which is located in the coiled-coil domain. Phosphorylation of a coiled-coil assembly may serve to regulate the conformation of the parent protein (30) . CKT2 was found to be phosporylated by recombinant purified CK2. GST pull-down and yeast two-hybrid assays showed that CKT2 binds to the CK2a 0 subunit. Furthermore, in testicular lysates immunoprecipitated for CKT2, CK2a 0 was co-immunoprecipitated, indicating that CK2a 0 binds to CKT2 endogenously. In addition, we showed that endogenous CK2a 0 immunoprecipitated from testicular lysates can phosphorylate CKT2. We also found that recombinant CKT2 is phosphorylated by CK2a 0 but that the regulatory subunit CK2b was required for the kinase activity of CK2a 0 . As shown in Figure 1A , there are six amino acid residues on CKT2 that are potential sites of phosphorylation by CK2. Although phosphorylation of one or more of these sites is likely necessary for full CKT2 function, future studies involving site-directed mutagenesis of each or more of these residues would be required to determine the consequences of their phosphorylation in regulating spermatid chromatin condensation. Furthermore, it is interesting to speculate that the serine-rich domain from amino acid positions 164-182 of CKT2 may be phosphorylated by an unknown kinase, creating an acidic region that may render CKT2 to be more susceptible to phosphorylation by CK2 ( Figure 1A) .
A study of the spatio-temporal dynamics of CK2 in living cells has revealed that both CK2a and CK2a 0 are located mostly in nuclei (31) . Immuno-electron microscopy revealed that CKT2 is present in spermatid nuclei undergoing chromatin condensation, consistent with previous findings in yeasts that CK2-induced gene expression are those that encode chromatin remodeling proteins (32) . CK2a 0 is highly expressed in testis (33) and appears to have an important role in survival and nuclear integrity of male germ cells (23, 24) . Genetic disruption of CK2 0 results in extensive nuclear alterations and apoptosis of differentiating male germ cells. Such morphologic changes in male germ cell differentiation include large nuclear envelope protusions and chromatin degeneration (24) . Our observation that CKT2 is highly expressed at a specific step of spermatid chromatin condensation suggests that CKT2 and CK2a 0 are involved in chromatin regulation during its remodelling. In spermatids undergoing condensation, somatic histones are replaced by lysinerich transition proteins and, in turn, transition proteins are replaced by relatively arginine-and cysteine-rich protamines (34, 35) , processes that indicate complex protein-DNA interactions (36) .
The TSPY testis-specific protein has already been found to play a role in the development of testicular cancer and prostate cancer. Interestingly, TSPY is known to be involved in chromatin remodelling and to be dependent on CK2 phosphorylation for its entrance into nuclei (37) . The unique testicular phenotype of CK2 0 À/À mice raises the question of whether CK2a 0 could contribute to the pathogenesis of male germ cell tumors. Current evidence indicate that elevated expressions of CK2a 0 are found in a number of metastatic tumors (38) . Nuclear localization of CK2a is associated with a poorer prognosis in human prostate cancer (14) . The anti-apoptotic function of CK2 may contribute to its ability to participate in transformation and tumorigenesis. CK2 activates histone deacetylase in hypoxia-associated tumors; in addition, upon hypoxic treatment, both CK2a and CK2a 0 shuttle into the nucleus where histone deacetylases are localized (39) . Administration of a peptide that targets the acidic phosphorylation domain for CK2 substrates has an anti-tumor effect in the mouse (17) . Furthermore, strategies to inhibit CK2 have been ongoing in preclinical trials (16) . Although CKT2 shares some homology with the oncogene product c-Myc (Supplementary Figure 1) , the relatively sparse expression of CKT2 in spermatogonia would argue against its role in the nuclear alterations seen in the spermatogonia of CK2 0 À/À mice and in testicular cancers. In summary, this study identified CKT2 as the first known target for CK2a 0 during spermatogenesis. CKT2 expression was found to parallel chromatin remodelling, suggesting important nuclear functions of CK2a 0 and CKT2 in germ cells. CK2 0 À/À mice and future development of a CKT2À/À mice will be important models to extend these studies. Future work needs to also address whether CKT2 is a CK2a 0 target in premeiotic male germ cells and various germ cell tumors. Such elucidation would be invaluable to the emerging work of generating male germ cells from embryonic stem cells (40) , given the known similarities between the primordial germ cells and embryonic stem cells (41, 42) .
